• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-500
Device Problems Imprecision (1307); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Encephalopathy (1833); Hypoglycemia (1912)
Event Date 10/28/2020
Event Type  Injury  
Manufacturer Narrative
The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Event Description
On october 29th 2020, senseonics was made aware of an adverse event where patient was hospitalized due to hypoglycemia with acute metabolic encephalopathy.
 
Manufacturer Narrative
The case notes clearly indicate that this incident has nothing to with device, insertion procedure or study procedure.Besides, the user was inserted on 27th october and date of event is 28th october.Once a customer is inserted with new sensor (i.E.27th october) there is a 24 hour warm up period during which no calibration is possible.After 24 hour warm up period, customer must put in 4 calibrations 2-12 hours apart and system starts showing glucose data after 2nd calibration entry.Dms confirms that customer was inserted on sensor on 27th october but system did not come out of initialization step and display glucose values until 31st october.All the 4 calibrations required for system to come out of initialization step were entered on 31st october.This confirms that system was not in use and hence the event was not related to device.No further investigation is required.H6.Health effect - clinical code updated to 1833 h6.Health effect -impact code updated to 4614 h6.Medical device problem code updated to 2993 h6.Component code updated to 4756 h6.Type of investigation updated to 4111 h6.Investigation findings updated to 3221 h6.Investigation conclusions updated to 4310.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
MDR Report Key10915752
MDR Text Key218643154
Report Number3009862700-2020-00575
Device Sequence Number1
Product Code QCD
UDI-Device Identifier00817491021441
UDI-Public00817491021441
Combination Product (y/n)Y
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 10/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/17/2020
Device Model Number102208-500
Device Catalogue NumberFG-3300-01-001
Device Lot Number116481
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/29/2020
Initial Date FDA Received11/28/2020
Supplement Dates Manufacturer Received10/29/2020
Supplement Dates FDA Received12/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age42 YR
-
-